Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Thomas LeBlanc
palliative care
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Sami Malek
blood cancer biology
Jennifer Lewis
URM Student
Loren Walensky
pediatric leukemia
Stacie Dusetzina
Equity in Access
Yiman Liu
Epigenetics and leukemia
Sahand Hormoz
MPN
Jeffrey Magee
pediatric AML
Robert Soiffer
transplantation
Zachary Hunter
Waldenström macroglobulinemia (WM)
Kura Oncology
MLL leukemia, AML
Hong Wen
AML
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Courtney Jones
AML metabolism
Nizar Bahlis
Myeloma immunotherapy
Christian Marinaccio
MLL leukemias
Brian Dalton
DNA mutations and myeloid cancers
Britta Will
Leukemia and pre-leukemia
Kathleen Sakamoto
pediatric AML
Suzanne Lentzsch
Myeloma
Joachim Yahalom
Lymphoma
Ryotaro Nakamura
ALL, CAR T
Wendy Béguelin
follicular lymphoma
Nitin Jain
CLL
Ari Melnick
epigenetics and lymphoma
Kirk Schultz
pediatric transplantation
Sameer Parikh
COVID-19
Ricky Johnstone
lymphoma and myeloma
Pietro Genovese
transplant and AML
Koichi Takahashi
AML/MDS
Carl June
CAR T immunotherapy
Sylvain Simon
Immunotherapy, CAR-T safety
Qing Yi
Novel CAR-T
Suman Paul
T cell cancers and immunotherapy
Randall Davis
CLL
Adam de Smith
pediatric ALL and Down Syndrome
Tycel Phillips
Mantle Cell Lymphoma
Jing Yang
Myeloma
Ryvu Therapeutics
AML, MDS
Stephen Oh
myeloproliferative neoplasms
Elliot Stieglitz
CMML
Markus Muschen
leukemia and lymphoma biology
Kimberly Stegmaier
childhood blood cancers
Timothy Graubert
AML and MDS biology
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Enterome
vaccine, FL, MZL
Michael Wang
Mantle Cell Lymphoma
Frederick Locke
lymphoma and immunotherapy
Roland Walter
Antibody-based AML therapies
Faron Pharmaceuticals
immunotherapy, MDS
Alex Herrera
lymphoma and immunotherapy
Coleman Lindsley
AML/MDS
Thorsten Zenz
Hairy cell leukemia
Daniel Lucas
bone marrow and leukemia biology
Jonathan Licht
DNA biology, myeloma
Lindsey Montefiori
pediatric leukemia
Daniel Herranz
T-ALL
Rgenta Therapeutics
RNA-targeting, blood cancer
Shirong Li
myeloma
Gianpietro Dotti
CAR T and AML
Carl Allen
pediatric blood cancers
Christian Steidl
B-cell lymphomas
Kerry Rogers
CLL
Alfred Garfall
myeloma immunotherapy
Enrico Tiacci
Hairy cell leukemia
Jennifer Trowbridge
aging and leukemia
Lakshmi Nayak
brain tumors in lymphoma
Susan Schwab
cancer immunology
Eric Padron
CMML
Shannon Maude
Immunotherapy for ALL
Alex Kentsis
pediatric leukemias
Tanya Siddiqi
clinical trial access
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Zhijian Qian
blood cancer stem cells
Kirsten Williams
leukemia, immunotherapy
George Vassiliou
Leukemia Prevention
Mala Shanmugam
myeloma
Alieen Rowan
Adult T cell leukemia/lymphoma
Christopher Booth
BPDCN
Eirini Papapetrou
blood cancer stem cells
Richard Lock
T-ALL
Caroline Arber
myeloma CAR-T
Eric Pietras
AML
Ruben Carrasco
Myeloma
Liling Wan
AML
Jolanta Grembecka
leukemia therapeutics
John Crispino
MPNs, myelofibrosis
Tyler Parsons
MPN and AML
Nirav Shah
CAR-T for lymphoma
Daisuke Nakada
preleukemia, leukemia
Jaehyuk Choi
T-cell lymphoma
Jun Qi
Myeloma
Baochun Zhang
immunotherapy
Margaret Shipp
lymphoma biology
Kehan Ren
MDS
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Marc Seifert
Hairy cell leukemia
Simona Colla
Myeloma biology
Alexandra Stevens
childhood AML
Huda Salman
CMML
Grant Challen
preleukemia, leukemia
Inhye Ahn
CLL
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Nathan Ungerleider
lymphoma biology
Rajni Kumari
AML
Christopher Flowers
clinical trial access
Mark Dawson
B-ALL and CAR-T resistance
Jianguo Tao
Mantle Cell Lymphoma
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Jaroslaw Maciejewski
bone marrow failure
Rong Lu
preleukemia, leukemia
Omar Abdel-Wahab
Hairy cell leukemia
Paolo Strati
Non-Hodgkin Lymphoma
Michael Rout
follicular lymphoma, CAR T
Jeremy Baeten
AML
Brian Walker
smoldering myeloma, MGUS
David Ritchie
Hairy Cell Leukemia
Jian Xu
leukemia and MPN biology
Reshmi Parameswaran
immunotherapy for hairy cell leukemia
Michael Kharas
leukemia
Gaurav Goyal
Erdheim-Chester Disease
Qingyu Luo
BPDCN
Kevin Shannon
pediatric AML
Charles Mullighan
pediatric ALL
Julia Maxson
AML
David Fruman
novel combinations
Mendel Goldfinger
MDS/AML trials for the elderly
Alison Moskowitz
lymphoma therapeutics
Robert Bradley
MDS
Michael Green
lymphoma biology
Therese Vu
T-All and MLL
Juliette Bouyssou
leukemias and gender
Logan Spector
childhood leukemia epidimiology
Tomasz Skorski
myeloproliferative neoplasms, AML
Caron Jacobson
lymphoma and immunotherapy
Christine Zhang
AML
Alec Zhang
myeloma, immunotherapy
Stephen Gottschalk
pediatric leukemia and CAR-T
Shan Lin
preleukemia, leukemia
Dimericon Therapeutics
dimericons, blood cancer
Affimed
immunotherapy, HL, PTCL
Daniel Thomas
Myelofibrosis
Samuel Taylor
leukemia biology
Saar Gill
AML immunotherapy
Matthew Frank
Lymphoma CART therapy
Gareth Morgan
smoldering myeloma, MGUS
Robert Kridel
follicular lymphoma
Maximilian Stahl
AML immunotherapy
Xu Ji
Equity in Access
Nicolas Nassar
pediatric leukemia
John Pimanda
AML, MDS
ImCheck Therapeutics
immunotherapy, AML
Abintus Bio
immunotherapy, in vivo CAR
Sean Post
diffuse large B-cell lymphoma
Bruno Paiva
smoldering myeloma
Trent Hall
MDS
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Steven Horwitz
T-cell lymphomas
Sam Butterworth
CMML
John Leonard
lymphoma research
Oreofe Odejide
Equity in Access
Sigurður Kristinsson
Smoldering myeloma
Catherine Smith
leukemia
Amit Verma
AML/MDS
Timothy Ley
AML, precision medicine
Jenny Wang
AML
Thomas Koehnke
leukemia
Luca Busino
DLBCL
Michael Savona
MDS and leukemia
Martin Dreyling
Mantle Cell Lymphoma
Keisuke Ito
blood cancer stem cells and MDS metabolism
Ronald Levy
immunotherapies, COVID-19
Siddhartha Jaiswal
preleukemia
Areej El-Jawahri
transplant survivorship
Katherine Borden
AML
Grzegorz Nowakowski
Clinical trial access
Dan Vogl
myeloma, microenvironment
Christopher Reilly
leukemia
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Andrew Lane
BPDCN
Shannon McKinney-Freeman
transplant biology
Marina Konopleva
MDS/AML metabolism
Adi Nagler
Bronchiolitis obliterans after transplant
Lori Muffly
Equity in Access
Jessica Stewart
Epstein-barr virus and lymphomas
Soheil Meshinchi
pediatric AML
Justine Kahn
pediatric leukemia and lymphoma
F. Lennie Wong
Equity in Access
Catriona Jamieson
cancer stem cell biology
Hao Jiang
leukemia biology
Eugenio Morelli
Myeloma
Selina Chen-Kiang
Mantle cell lymphoma
Ryan Wilcox
T-cell lymphoma
Lev Kats
myeloma and epigenetics
Courtney DiNardo
clinical trials, AML
Jennifer Woyach
CLL trials
Megan McNerney
AML/MDS
Jason Butler
aging and leukemia
Christiane Querfeld
T-cell lymphoma
Lawrence Boise
CART and myeloma
Alexey Danilov
lymphoma
Yubin Zhou
peripheral T cell lymphoma
Anna Lee
AML
Daniel Starczynowski
MDS and AML
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Maria "Ken" Figueroa
aging and leukemia
Sattva Neelapu
DLBCL, CAR T
Matteo Bellone
Smoldering multiple myeloma
Amer Zeidan
MDS and AML
Tak Mak
Immunotherapy
Noemí Puig Morón
Myeloma
Robert Orlowski
(Smoldering) Multiple Myeloma
Meng Li
Equity in Access
Takeshi Sugio
T-cell lymphoma
BioInvent International
immunotherapy, indolent NHL, CTCL
Christopher Porter
Leukemia, lymphoma
Lucy Godley
preleukemia
Helen Heslop
Immunotherapy
G. Greg Wang
DNA biology
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Rizwan Romee
Immunotherapy
Liran Shlush
pre-leukemia
Venkata Lokesh Battula
immunotherapy and AML
Dan Landau
cancer evolution biology
Thomas Kipps
Hairy Cell Leukemia
Frederike Kramer
MPNs
Steven Treon
Lymphomas and Waldenstrom's
Neha Mehta-Shah
T-cell lymphoma
Ann-Kathrin Eisfeld
Racial diversity in AML
Peng Ji
myeloproliferative neoplasms
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Larry Kwak
Mantle cell lymphoma, immunotherapy
Amin Sobh
Myeloma biology
Catherine Bollard
pediatric blood cancers and immunotherapy
Julia Paczkowska
immunobiology of Hodgkin's disease
Srividya Swaminathan
pediatric, immunotherapy
Mark Hamilton
DLBCL and CAR-T
Taishi Yonezawa
AML
Michael Keller
COVID-19, immunotherapy
Armin Rashidi
gut bacteria and transplant success
Wendy Stock
T-cell ALL
William Matsui
Myeloma
Adam Olszewski
Follicular and marginal zone lymphoma
Yusuke Isshiki
DLBCL and GCB Lymphomas
Ravi Bhatia
transplantation
Caner Saygin
T-ALL
Roberta Zappasodi
lymphoma, immunotherapy
Sergei Doulatov
Leukemias
Ravindra Majeti
preleukemia, AML
Jalpa Doshi
Equity in Access
Piers Patten
COVID-19
Stephen Nimer
myeloid cancer biology
Sisi Chen
leukemia
Daniel Pollyea
AML
Marco Ruella
Immunotherapy for T-cell lymphoma
Jonathon Cohen
lymphoma clinical trial access in Georgia
Jonas Jutzi
myeloproliferative neoplasms
Jianhua Yu
myeloma immunotherapy
Peter Klein
MDS
Dane Vassiliadis
blood cancer biology
Yan Liu
MDS
Arash Alizadeh
blood cancer biology and diagnosis
Kasey Leger
pediatric blood cancers
Cailin Collins
Leukemia and pre-leukemia
Constellation Pharmaceuticals
myeloproliferative neoplasms
Mitchell Geer
leukemia biology
Yibin Yang
Lymphoma
Riccardo Dalla-Favera
lymphoma (DLBCL)
Craig Jordan
AML
Sarah Tasian
pediatric leukemias
Aditi Shastri
AML, MDS
Helen Parsons
Equity in Access
Madhav Dhodapkar
multiple myeloma immunotherapy
Jayna Mistry
aging and leukemias